Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 2 |
2018 | 2 |
2020 | 2 |
2021 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Validation of the Return To Work Self-Efficacy questionnaire in a population of employees undergoing treatment for cancer.
Eur J Cancer Care (Engl). 2021 Mar;30(2):e13373. doi: 10.1111/ecc.13373. Epub 2020 Nov 20.
Eur J Cancer Care (Engl). 2021.
PMID: 33216404
Male breast cancer: a nation-wide population-based comparison with female breast cancer.
Lautrup MD, Thorup SS, Jensen V, Bokmand S, Haugaard K, Hoejris I, Jylling AB, Joernsgaard H, Lelkaitis G, Oldenburg MH, Qvamme GM, Soee K, Christiansen P.
Lautrup MD, et al. Among authors: hoejris i.
Acta Oncol. 2018 May;57(5):613-621. doi: 10.1080/0284186X.2017.1418088. Epub 2017 Dec 23.
Acta Oncol. 2018.
PMID: 29276849
Item in Clipboard
The Predictive Value of Return to Work Self-efficacy for Return to Work Among Employees with Cancer Undergoing Chemotherapy.
Rosbjerg R, Hansen DG, Zachariae R, Hoejris I, Lund T, Labriola M.
Rosbjerg R, et al. Among authors: hoejris i.
J Occup Rehabil. 2020 Dec;30(4):665-678. doi: 10.1007/s10926-020-09882-2.
J Occup Rehabil. 2020.
PMID: 32114672
Free PMC article.
Item in Clipboard
Physical activity, return to work self-efficacy, and work status among employees undergoing chemotherapy for cancer - a prospective study with 12 months follow-up.
Rosbjerg R, Zachariae R, Hansen DG, Hoejris I, Duijts S, Gehr NL, Andersen ID, Labriola M.
Rosbjerg R, et al. Among authors: hoejris i.
BMC Cancer. 2021 Feb 17;21(1):169. doi: 10.1186/s12885-021-07824-6.
BMC Cancer. 2021.
PMID: 33596859
Free PMC article.
Item in Clipboard
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Colleoni M, Luo W, Karlsson P, Chirgwin J, Aebi S, Jerusalem G, Neven P, Hitre E, Graas MP, Simoncini E, Kamby C, Thompson A, Loibl S, Gavilá J, Kuroi K, Marth C, Müller B, O'Reilly S, Di Lauro V, Gombos A, Ruhstaller T, Burstein H, Ribi K, Bernhard J, Viale G, Maibach R, Rabaglio-Poretti M, Gelber RD, Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators.
Colleoni M, et al.
Lancet Oncol. 2018 Jan;19(1):127-138. doi: 10.1016/S1470-2045(17)30715-5. Epub 2017 Nov 17.
Lancet Oncol. 2018.
PMID: 29158011
Clinical Trial.
Item in Clipboard
Cite
Cite